CRO

TaiMed is a digital operation platform for the life sciences industry, covering pharmaceutical R&D, pharmacovigilance, and pharmaceutical marketing.

FAST NEWS: TaiMed tumbles in Hong Kong trading debut

The Latest: Shares of Zhejiang Taimei Medical Technology Co. Ltd. (2576.HK) opened at HK$11.24 in their Tuesday trading debut, down 13.5% from their IPO price of HK$13, giving the medical…
2576.HK
During the Covid pandemic, lab monkeys that are one of Joinn’s main businesses were in short supply as companies rushed to develop Covid vaccines and drugs.

FAST NEWS: Joinn Lab swings to the red on falling revenue

The Latest: Joinn Laboratories (China) Co. Ltd. (6127.HK; 603127.SH), China’s leading non-clinical contract research organization (CRO), said on Wednesday it expects to report a net loss of 136 million yuan ($18.7…
6127.HK 603127.SHG
Contract drug services provider WuXi Biologics announced on Wednesday it has raised its guidance for new projects in 2024 from 80 to 110, despite a slowdown in biotech financing, after seeing a strong recovery in demand in the second half of last year.

FAST NEWS: WuXi Biologics boosts new projects target

The latest: Contract drug services provider WuXi Biologics (Cayman) Inc. (2269.HK) announced on Wednesday it has raised its guidance for new projects in 2024 from 80 to 110, despite a…
2269.HK

Joinn profits slide as lab monkey build-up backfires

The leading provider of pre-clinical drug research has predicted its first-half profits will plummet between 70% and 80% due to the falling value of its lab animals Key Takeaways: Joinn…
6127.HK 603127.SHG

Recent Articles

RELATED ARTICLES

  1. So-Young dolls up with move to high-end cosmetic surgery
    So-Young dolls up with pivot to high-end services
    SY.US
  2. HealthyWay seeks Hong Kong IPO to staunch flow of red ink
  3. IFlytek hives off health unit to fund AI medical drive
    002230.SHE
  4. Bayzed joins IPO quest as medical rivalry heats up
  5. Payment app Lianlian seeks IPO relief from cash crunch
  6. Third time’s the charm: Fangzhou finally finds winning tonic for Hong Kong IPO
    6086.HK
  7. Baiwang eyes Hong Kong IPO to support its money-hungry loan facilitation business
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva